Therapeutic drug monitoring for immunosuppressants
- 30 October 2001
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 313 (1-2) , 241-253
- https://doi.org/10.1016/s0009-8981(01)00678-7
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Recommendations for Bioequivalence Testing of Cyclosporine Generics RevisitedTherapeutic Drug Monitoring, 2000
- Pharmacoeconomics of Therapeutic Drug Monitoring in TransplantationTherapeutic Drug Monitoring, 2000
- Cyclosporine Plasma Unbound Fraction in Heart and Lung Transplantation RecipientsTherapeutic Drug Monitoring, 1999
- EditorialTherapeutic Drug Monitoring, 1996
- Proceedings of the International Consensus Conference on Immunosuppressive DrugsTherapeutic Drug Monitoring, 1995
- Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994
- A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomeraseNature, 1989
- FK-506 — How much potential?Immunology Today, 1989
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1987